Risperdal judgement reversed

|By:, SA News Editor

The Arkansas Supreme Court reverses the $1.2B judgment against Johnson & Johnson (JNJ) for improperly marketing the anti-psychotic drug Risperdal.

The court overturned the state's case because it had sued under a law covering health care facilities instead of drug companies.